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Midterm outcomes of femoral arteries after
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W. Anthony Lee, MD, Michael P. Brown, DO, Peter R. Nelson, MD, Thomas S. Huber, MD, PhD, and
James M. Seeger, MD, Gainesville, Fla
Objective: Percutaneous access during endovascular aortic repair has been shown to be feasible and safe using a
suture-mediated closure device (“Preclose” technique) for closure of up to 24F introducer sheaths. The purpose of this
study is to examine the late outcomes of those femoral arteries repaired in this manner.
Methods: The Preclose technique has been previously described. Briefly, the technique involves two Perclose Proglide
devices deployed in the femoral artery prior to insertion of the large diameter introducer sheath and then closure of the
arteriotomy by tying down knots of the Proglide following removal of the sheath. The medical records of all patients who
underwent endovascular aortic repairs using the Preclose technique between December 2004 and August 2007 were
reviewed. Follow-up protocol consisted of computed tomography (CT) angiograms performed at 1, 6, and 12 months,
and annually thereafter. All Preclose patients who had at least a 6-month postoperative scan were included in the study.
For each patient, the most recent postoperative scan was compared with the preoperative scan for evidence of any new
anatomic abnormalities of the femoral artery such as dissection, stenosis, or pseudoaneurysm. Three-dimensional post
processing with multiplanar reconstructions was also performed as necessary to confirm axial scan findings.
Results: A total of 292 patients underwent percutaneous endovascular aortic repairs (TEVAR-125, EVAR-167). Four
hundred thirty-two femoral arteries were closed with 870 devices. Four hundred eighteen vessels were approximated with
two devices, while 30 arteries required three devices for hemostasis and an additional four vessels only required a single
device. Two hundred seventy-eight (64.3%) vessels were accessed with sheaths 18 to 24F. Four hundred eight femoral
arteries (94.4%) were closed successfully with the Preclose technique. There were 100 patients (TEVAR-35, EVAR-65)
who had adequate postoperative CT scan at 6-months or later. The mean follow up was 11.6  5.0 months. Of the 156
femoral arteries in these 100 patients repaired using the Preclose technique, there were 3 late complications in 3 patients,
1 asymptomatic femoral artery dissection, and 2 femoral artery pseudoaneurysms requiring surgical repair, resulting in a
late complication rate of 1.92% (3/156).
Conclusion: Percutaneous closure of femoral arteries after large diameter introducer sheaths using the Preclose technique
has a low incidence of early and late complications related to the closure site. ( J Vasc Surg 2008;47:919-23.)Suture-mediated closure devices are commonly used
for percutaneous management of small diameter (6-10F)
sheaths without the need for manual compression or pro-
longed bedrest. Their use for closure of larger (18-24F)
sheaths during endovascular abdominal (EVAR) and tho-
racic (TEVAR) aortic repairs has been previously reported
with technical success rates ranging from 62% to 100%.1-13
We have previously reported the early outcomes in a large
cohort of patients undergoing endovascular aortic repairs
using the Perclose Proglide device (Abbott Vascular, Red-
wood City, Calif).12 In this study, we report on the late
outcomes of femoral arteries in these patients percutane-
ously closed using this technique.
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The medical records and imaging studies of all endo-
vascular aortic repairs (EVAR/TEVAR) performed percu-
taneously using the Preclose technique12 at a single tertiary
care medical center during the period from December
2004 to August 2007 were reviewed. The endovascular
procedures consisted of percutaneous access requiring
12-24F (internal diameter, corresponding outer diameter:
14-27F, 4.4-8.6 mm) sheaths. All patients were followed
postoperatively with history and physical examinations and
computed tomography (CT) angiography at 1, 6, and 12
months, and annually thereafter. Only those patients with
at least 6-month follow-up were included in the study.
Standard CT angiography protocol included intrave-
nous contrast enhanced, timed-bolus, thin-cut (2-mm),
arterial-phase acquisitions using Toshiba (Tustin, Calif) or
Siemens (Malvern, Penn) 32/64 multi-row detector array
scanners. The caudal extent of the scan extended beyond
the femoral heads so that the entire femoral bifurcation was
visualized. The source images were examined and post-
processed using the Aquarius Workstation (TeraRecon,
San Mateo, Calif) and analyzed with three-dimensional
multiplanar reconstructions. The most recent CT scan was
reviewed and compared with preoperative imaging for evi-
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the access site such as dissection, stenosis, pseudoaneurysm,
arteriovenous fistula, hematoma, or other soft tissue mass
or inflammation.
Early technical success (in-hospital or 30-day) was de-
fined as closure of the arteriotomy without the need for any
adjunctive surgical or endovascular procedures. Any access-
related complications such as hematomas with or without
transfusions or wound infections that led to prolongation
of hospitalization were counted as failures of the therapy
regardless of whether they required additional postopera-
tive surgical or endovascular intervention. Late complica-
tions were considered as those events (hemorrhagic, infec-
tious, or ischemic, and symptomatic or asymptomatic)
occurring after discharge and 30 days postoperatively.
Aggregate results are reported as mean  standard
deviation. Unless specified, event rates were analyzed per
femoral artery and on an intention-to-treat basis. Categor-
ical data were analyzed using Fisher exact test with signifi-
cance at P  .05. This study was approved by the Institu-
tional Review Board.
Perclose Proglide. This is a 6F suture mediated closure
device that is inserted over an 0.035-inch guidewire and
designed to close arteriotomies after 5-7F sheaths. A single
3-0 polypropylene suture is deployed with a full thickness
vertically-oriented bite of the artery using a pair of nitinol
needles. A preformed slipknot is already in place. The two
strands of the single suture are color-coded to indicate the
tying strand and the locking strand. The arteriotomy is
closed by pulling on the tying strand, pushing down the
preformed slipknot using the accompanying knot pusher,
and locking the knot by retracting on the locking strand.
The guidewire is removed during the deployment of the
sutures, but is replaced prior to removal of the device to
maintain access to the artery. It should be noted that the
use of this device as described in this study is off-label.
Preclose technique. The common femoral artery was
accessed percutaneously using a micropuncture kit (Galt
Medical, Garland, Tex). Care was taken to puncture the
common femoral artery along its anterior aspect at least
1-cm proximal to the origin of the profunda femoris artery.
This was always confirmed with femoral angiography in an
ipsilateral oblique projection. An 0.035-inch guidewire was
inserted into the aorta and the puncture site dilated with a
7F sheath. A Proglide device was advanced over the guide-
wire, rotatedmedially approximately 30° and deployed, but
the strands were left out extracorporeally and tagged with a
small clamp. Guidewire access was maintained and a second
Proglide device was inserted, rotated laterally 30° and
deployed. After this device was removed, hemostasis was
maintained by re-inserting the 7F sheath. This procedure
was repeated for the contralateral side for EVAR (unilateral
for TEVAR).
After conclusion of the endovascular repair, the intro-
ducer sheaths are slowly removed while applying manual
compression to the groin. Stiff 0.035-inch guidewire access
is maintained and the preformed knots of the two sutures
are tied down over the guidewire. Manual pressure isreleased from the groin and after verification of adequate
hemostasis, the guidewire is removed, and manual pressure
is re-applied to the groin. On the discretion of the operator,
a third Proglide device was deployed, if needed. Distal
perfusion is checked with a continuous-wave Doppler
probe and anticoagulation is fully-reversed to restore the
activated clotting time (ACT) to less than 150 seconds.
Compression is maintained for 5-10 minutes and the pa-
tient is kept at bedrest for 4-6 hours.
RESULTS
Between December 2004 and August 2007, 292 pa-
tients underwent percutaneous endovascular aortic repairs
(125 TEVAR, 167 EVAR). Four hundred thirty-two fem-
oral arteries were closed with 870 Proglide devices (2.01
devices/artery). Four femoral arteries (0.9%) required only
one device, 418 (96.8%) were closed with two devices, and
10 arteries (2.3%) needed a third device. The distribution of
sheath sizes is given in Fig 1. Large size sheaths (18F)
were used in over 64% (278/432) femoral arteries. The
bodymass index (BMI) was available in 214 (73%) patients.
The mean BMI was 27.2  4.7 kg/m2.
There were 24 early Preclose failures requiring open
repair of 20 femoral arteries, emergent placement of a
covered stent (Viabahn, WL Gore, Flagstaff, Ariz) in two
arteries to treat active retroperitoneal hemorrhage, one
mycotic pseudoaneurysm requiring autogenous femoral
reconstruction on postoperative day (POD) 27 with a
femoral vein conduit, and one rapidly expanding pseudo-
aneurysm in a coagulopathic patient (Fig 2). This last
patient presented on POD 12 with a large pulsatile mass
and an International normalized ratio (INR) of 6.0 from
chronic anticoagulation for a prosthetic aortic valve. Dur-
ing repair of the pseudoaneurysm, the ipsilateral limb of the
bifurcated endograft thrombosed due to inadequate intra-
operative anticoagulation and it could not be re-opened.
The patient underwent a femoral-femoral bypass graft with
a sartorius flap. His course was complicated by a severe,
suppurative cellulitis of both groin wounds that required
Fig 1. Distribution of sheath sizes. Solid bars represent techni-
cally successful closure. Stippled bars represent early failures for
each sheath size.multiple, serial operative debridements.
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nique was 94.4% (408/432). In the subset of 12-16F
sheaths, the success rate was 98.7%, while for the larger
18-24F sheaths, the success rate was lower at 92.8% (P 
.005). There was no access related mortality.
There were 100 patients (TEVAR-35, EVAR-65) who
had an adequate postoperative CT scan at 6 months or
later. In this subset of patients, 156 femoral arteries were
percutaneously closed using 313 Proglide devices. The
sheath distribution was: 12F-10, 14F-29, 16F-21, 18F-29,
20F-35, 22F-11, and 24F-21. The mean follow-up of this
group was 11.6  5.0 months. There were three late
complications: one asymptomatic common femoral artery
dissection detected on CT angiography (Fig 3), and two
femoral artery pseudoaneurysms requiring repair. The rate
of late complications was 1.92% (3/156). Freedom from
late complications based on Kaplan-Meier analysis was
97.4% at 12 months (Fig 4).
Late complications in detail. The one patient with
the femoral artery dissection denied any claudication and
had normal femoral pulses on exam. The lesion was present
in the 1 month postoperative scan, and at his 16-month
follow-up, the dissection remained stable without evidence
of progression. The first patient with a late pseudoaneu-
rysm had an immediate surgical conversion and repair of
the femoral artery with a prosthetic patch angioplasty after
a failed Preclose attempt. He presented with an enlarging
but asymptomatic pseudoaneurysm on his first postopera-
tive CT scan obtained on POD 133. This was electively
repaired with polytetrafluoroethylene (PTFE) interposition
graft. The second patient presented with a draining sinus
tract from his puncture site on POD 48. This was explored
and packed. The wound had completely healed, but pre-
sented 6 months later with a large abscess and femoral
thrombosis. He underwent thrombectomy and femoral
replacement with a bovine carotid graft. This was later
complicated by an acute pseudoaneurysm and necrotizing
Fig 2. Acute right femoral pseudoaneurysm after Preclose tech-
nique used to close a 20F sheath after endovascular abdominal
presenting on POD 12.infection of the bovine graft 3 weeks later. He underwentwide debridement, a redo femoral replacement with an-
other bovine carotid graft, and sartorius flap.
DISCUSSION
The technique of percutaneous closure of femoral ar-
teries after endovascular aortic repair was initially described
by Haas et al in 1999.1 Since then, there have been a
number of other published series reporting technical suc-
cess rates ranging from 62% to 100%.1-13 Although the
majority of the published experience has utilized the 10F
Prostar (Abbott Perclose, Redwood City, Calif) device, a
Fig 3. Sagittal thin-cut MIP (maximum intensity projection) of
asymptomatic focal left femoral dissection detected at 16 months
postoperatively. A, Preop. B, Postop.
Fig 4. Freedom from late complications after Preclose based on
Kaplan-Meier analysis. SE, Standard error.larger series using the Proglide device appeared to show a
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of the particular device or technique, however, the closure
rates appear to be dependent on the sheath size, with
smaller size sheaths (12-16F) having a higher rate of success
than larger sizes (18-24F), as expected.5,9-12
It had been previously noted by our group and others
that coagulopathy12 and obesity10,12 were relative contra-
indications for using the Preclose technique. Since that
initial report, the single new patient who presented with an
acute pseudoaneurysm had both of these risk factors with a
BMI of 56 kg/m2 and over-anticoagulation from warfarin
for his mechanical aortic valve. With increasing experience,
we have successfully applied the Preclose technique on
obese patients and over 25% of our entire cohort had a BMI
30 kg/m2. However, we believe that the need to perio-
peratively anticoagulate the patient contributed to the de-
layed formation of the pseudoaneurysm in this case.
The critical importance of maintaining stiff guidewire
access until confirmation of adequate hemostasis cannot be
overemphasized.12,13 In cases of Preclose failure, the
guidewire allows the bleeding to be immediately and com-
pletely controlled with a simple reinsertion of a dilator and
prevent a life-threatening hemorrhagic complication. Thus,
it allows an unhurried surgical repair of the femoral artery.
Fortunately, when the Preclose technique fails, it is usually
obvious as manifested by ongoing pulsatile bleeding from
the puncture site, rapid hypotension in cases of a retroper-
itoneal hemorrhage, or acute distal ischemia with absent
pedal pulses. Twenty-two of the 24 acute failures were
recognized immediately before leaving the operating room.
At exploration, hemorrhagic failures typically show intact
sutures but persistent pulsatile bleeding through the arte-
riotomy. It should be kept in mind that inspection of the
sutures at the time of exploration does not duplicate the
conditions under which the Perclose sutures typically per-
form their function, ie, the perivascular tissue that is part of
the hemostatic mechanism of the Preclose technique has
been completely dissected away, and the artery has been
“decompressed” by vascular clamps applied proximal and
distal to the bleeding arteriotomy. In contrast, ischemic
failures are due to a posterior plaque which has fractured
and caused a local dissection occluding the distal flow.
The patency of the repaired vessel after Preclose closure
appears to be maintained long term as demonstrated by
absence of any new occlusive lesions at the site of the
arteriotomy. Indeed, the single lesion (focal dissection)
that was found on late follow-up was clinically asymptom-
atic. Although there are no comparative long-term studies
of arteries closed with the Prostar device, we believe that
the use of interrupted, simple, full-thickness bites with
polypropylene suture of the Proglide device duplicates
closely conventional surgical techniques of arteriotomy clo-
sure and may contribute to this low incidence of late
intraluminal defects.
There were four pseudoaneurysms in this series. Al-
though one was not directly related to the Preclose tech-
nique itself but to the surgical patch repair of the femoral
artery used to treat an early failure, it was considered a latecomplication of the Preclose technique when analyzed on
an intention-to-treat basis. Two of the pseudoaneurysms
were mycotic from secondary infection of the Perclose
sutures and one from coagulopathy. Regardless of the
etiology of the pseudoaneurysms, they all required major
arterial reconstructions with significant morbidity. This
emphasized the importance of maintaining strict aseptic
technique and normal coagulation in the perioperative
period.
The main limitation of this study was the relatively
limited size of the late cohort. Despite the initial group of
292 patients, only 100 (34%) of these had adequate clinical
follow-up and imaging studies at 6 months, and primarily
consisted of the earlier segment of our overall experience.
This low compliance rate was due tomultiple reasons. First,
the patients accrued in the last 6 months of the study
(February to August 2007) did not yet have their 6 month
CT scans at the time the data was gathered. Second, as with
many tertiary care centers, many of the patients came from
far distances and, after their 1-month visit, they were al-
lowed to obtain their CT scans locally; unfortunately in
many instances, although these outside CT scans were
adequate to assess the aorta, they were inadequate to assess
the femoral vessels. And, third, many of these scans, which
were sent to our institution either as printed hard copies or
on CD-ROMs, were unavailable at the time of the data
collection to be retrospectively reviewed. Therefore, the
subset of patients on which the late follow-up results were
based mostly represented those whose postoperative imag-
ings were performed at our institution.
In conclusion, the high immediate success of the Pre-
close technique appears to be maintained on midterm
follow-up with a very low incidence (2%) of late compli-
cations and, in particular, development of new occlusive
lesions leading to symptomatic limb ischemia.
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